Moderna, Inc (formerly ModeRNA Therapeutics until 2018) is an American biotechnology company, founded in 2010 and based in Cambridge, Massachusetts, that aims to develop "protein therapies" based on messenger ribonucleic acid (messenger RNA)

MSD is a global pharmaceutical company providing innovative healthcare solutions through its prescription medicines (mainly in oncology and infectious diseases), vaccines and animal health products. For 130 years, MSD has been inventing for

The Faculty of Veterinary Medicine of National University of Life and Environmental Sciences of Ukraine carries out training of specialists in the field of "Veterinary Medicine" for the agro-industrial complex of Ukraine. Currently,

Founded in 1929 in Barcelona, Spain, REIG JOFRE is a pharmaceutical company listed on the Spanish Stock Exchange market, under the ticker RJF, dedicated to the research, development, manufacture and marketing of pharmaceutical

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice

USP, as the major institution of higher learning and research in Brazil, is responsible for educating a large part of Brazilian Masters and Ph.D’s. The University of São Paulo (USP) is a public

Seppic, an Air Liquide Healthcare company, has been a subsidiary of the Air Liquide Group since 1986. For over 75 years, Seppic has developed, manufactured, and marketed unique ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary, and

Speranza Therapeutics is a clinical-stage Biotech with a Focus on COVID-19 Vaccine Development Located at the heart of Frankfurt am Main, Speransa Therapeutics is led by a dedicated and highly-specialized team, with a

The Sphère unit (Sciences, Philosophy, History) UMR7219 was created in 2009 from the meeting of two units: the CHSPAM (Centre of History of Sciences and Arab and Medieval Philosophies, former UMR 7062), created

The TuBerculosis Vaccine Initiative (TBVI) is a Research and Innovation partnership that facilitates the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people. As